Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Impact on Sympathetic Vasoconstriction
NCT05244694Phase 1Completed
- Sponsor
- University of Missouri
- Start
- Aug 2020
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human insulin in insulin resistance (IR), sponsored by University of Missouri. Primary endpoint: Amount of leg blood flow. Started Aug 2020; status: completed.
02
Drugs
human insulin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT05244694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244694.